|
|
||||||||

* Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Womens Hospital; and
Combined Program in Pediatric Gastroenterology and Nutrition, Childrens Hospital, and Harvard Medical School, Boston, Massachusetts
Correspondence: Sean P. Colgan, Ph.D., Brigham and Womens Hospital, Center for Experimental Therapeutics and Reperfusion Injury, Thorn 704, 75 Francis Street, Boston, MA 02115. E-mail: colgan{at}zeus.bwh.harvard.edu
Neutrophil-induced damage to the protective epithelium has been implicated in mucosal disorders associated with hypoxia, and such damage may be initiated by epithelial-derived chemokines. Because chemokines can bind to membrane proteoglycans, we hypothesized that chemokines may associate with epithelial surfaces and activate polymorphonuclear neutrophils (PMN). Epithelial hypoxia (pO2 20 torr) resulted in a time-dependent induction of interleukin-8 (IL-8) mRNA, soluble protein, as well as surface protein. Such surface IL-8 expression was demonstrated to be dependent on heparinase III expression, and extensions of these experiments indicated that hypoxia induces epithelial perlecan expression in parallel with IL-8. Finally, co-incubation of post-hypoxic epithelia with human PMN induced IL-8-dependent expression of the PMN ß2-integrin CD11b/18. These data indicate that chemokines liberated from epithelia may exist in a surface-bound, bioactive form and that hypoxia may regulate proteoglycan expression.
Key Words: interleukin-8 mucosal disorders hypoxia
This article has been cited by other articles:
![]() |
W. Zheng, J. Kuhlicke, K. Jackel, H. K. Eltzschig, A. Singh, M. Sjoblom, B. Riederer, C. Weinhold, U. Seidler, S. P. Colgan, et al. Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium FASEB J, January 1, 2009; 23(1): 204 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Solic, J. Wilson, S. J. Wilson, and J. K. Shute Endothelial Activation and Increased Heparan Sulfate Expression in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 892 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. GOTTE Syndecans in inflammation FASEB J, April 1, 2003; 17(6): 575 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Narravula and S. P. Colgan Hypoxia-Inducible Factor 1-Mediated Inhibition of Peroxisome Proliferator-Activated Receptor {{alpha}} Expression During Hypoxia J. Immunol., June 15, 2001; 166(12): 7543 - 7548. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Furuta, J. R. Turner, C. T. Taylor, R. M. Hershberg, K. Comerford, S. Narravula, D. K. Podolsky, and S. P. Colgan Hypoxia-inducible Factor 1-dependent Induction of Intestinal Trefoil Factor Protects Barrier Function during Hypoxia J. Exp. Med., April 30, 2001; 193(9): 1027 - 1034. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |